Search

everythinglearnresearchcommunity

for

Search:↓

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.